½ÃÀ庸°í¼­
»óǰÄÚµå
1604681

¼¼°èÀÇ ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Artificial Intelligence in Neurology Operating Room Market by Offering (Services, Software), Application (Brain Mapping, Epilepsy Diagnosis, Integration & Connectivity), Indication - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 196 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É(Artificial Intelligence in Neurology Operating Room) ½ÃÀåÀº 2023³â 1¾ï 757¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 1¾ï 4,062¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç CAGR 32.24%·Î ÃßÀÌÇÏ¸ç ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 7¾ï 6,085 ¸¸¹Ì ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É(AI)ÀÇ ¹üÀ§´Â ¼ö¼ú Àü °èȹ, ¼ö¼ú Áß ³»ºñ°ÔÀ̼Ç, ¼ö¼ú ÈÄ ºÐ¼®¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¸¦ Æ÷ÇÔÇÕ´Ï´Ù. Á¤¹Ðµµ¸¦ ³ôÀ̰í, Àΰ£ÀÇ ¿À·ù¸¦ ÁÙÀ̸ç, ¼ö¼ú °á°ú¸¦ °³¼±Çϱâ À§Çؼ­´Â ¸Ó½Å·¯´×, ÄÄÇ»ÅÍ ºñÀü, ·Îº¿ ÀÚµ¿È­¿Í °°Àº AI ±â¼úÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ ±â¼úÀÇ ÀÀ¿ë ºÐ¾ß´Â ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®, ¿µ»ó ±â¼ú°úÀÇ ÅëÇÕ, ÃÖ¼Ò Ä§½ÀÀû ½Ã¼ú Áö¿ø µîÀÔ´Ï´Ù. ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀڷδ ȯÀÚ Ä¡·á °³¼±À» À§ÇÑ AI ±â¹Ý µµ±¸ÀÇ ÇýÅÃÀ» ¹Þ´Â ½Å°æ¿Ü°ú ÀÇ»ç, º´¿ø, Àü¹® ½Å°æ°ú Ŭ¸®´Ð µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀº ÁÖ·Î AI ±â¼úÀÇ ¹ßÀü, ½Å°æ Áúȯ »ç·ÊÀÇ Áõ°¡, º¸´Ù È¿À²ÀûÀ̰í È¿°úÀûÀÎ ¼ö¼ú ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä¿¡ ÀÇÇØ ¿µÇâÀ» ¹Þ½À´Ï´Ù. »õ·Ó°Ô ¶°¿À¸£´Â ±âȸ·Î´Â ½Ã°¢È­ °³¼±À» À§ÇÑ Áõ°­ Çö½Ç°ú AIÀÇ ÅëÇÕ, °³ÀÎ ¸ÂÃãÇü ȯÀÚ Ä¡·á °èȹÀ» À§ÇÑ ¿¹Ãø ºÐ¼® µîÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱ⠺ñ¿ë, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹®Á¦, Àü¹® ±³À°ÀÇ Çʿ伺 µîÀÇ µµÀü °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ Àå¾Ö¹°°ú ÀÇ·á ȯ°æ¿¡¼­ AI ±â¼úÀÇ ´À¸° äÅÃÀº »ó´çÇÑ ÇѰ踦 ÃÊ·¡ÇÕ´Ï´Ù. Çõ½Å°ú ¿¬±¸¸¦ À§ÇÑ ÃÖ¼±ÀÇ ºÐ¾ß´Â ±âÁ¸ º´¿ø ÀÎÇÁ¶ó¿Í ¿øÈ°ÇÏ°Ô ÅëÇÕÇÒ ¼ö ÀÖ´Â »óÈ£ ¿î¿ë °¡´ÉÇÑ AI ½Ã½ºÅÛ °³¹ß, ¹æ´ëÇÑ ÀÇ·á µ¥ÀÌÅÍ¿¡¼­ ½ÇÇà °¡´ÉÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ´Â AIÀÇ ´É·Â Çâ»óÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¿µ»ó ¹× Áø´Ü¿¡¼­ ´õ ³ôÀº Á¤È®µµ¸¦ À§ÇØ AI ¾Ë°í¸®ÁòÀ» Çâ»ó½ÃŰ´Â µ¥ ÀáÀç·ÂÀÌ ÀÖ½À´Ï´Ù. ½Å°æ¿Ü°ú ¼ö¼ú½Ç ½ÃÀåÀÇ AI°¡ ¼º¼÷ÇØÁü¿¡ µû¶ó ±â¼ú ±â¾÷°ú ÀÇ·á Á¦°ø¾÷ü °£ÀÇ Çù¾÷ÀÌ Çõ½ÅÀ» ÃËÁøÇÏ´Â µ¥ ÇʼöÀûÀÏ °ÍÀÔ´Ï´Ù. Àü¹ÝÀûÀ¸·Î ½ÃÀåÀº ±â¼ú Çõ½Å¿¡ ÀÇÇØ ÁÖµµµÇ´Â ¿ªµ¿ÀûÀΠȯ°æ°ú ÁøÈ­ÇÏ´Â ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©·Î Ư¡Áö¾îÁ® »ó´çÇÑ ¼ºÀåÀ» ÀÌ·ê Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù. ±âÁ¸ °úÁ¦¸¦ ÇØ°áÇÏ´Â µ¥ ÅõÀÚÇÏ°í »ç¿ëÀÚ Ä£È­ÀûÀ̰í È¿À²ÀûÀÎ AI ¼Ö·ç¼Ç¿¡ ÁýÁßÇÏ´Â ±â¾÷µéÀº ÀÌ ±Þ¼ºÀåÇÏ´Â ºÐ¾ß¿¡¼­ ¹øÃ¢ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 1¾ï 757¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 1¾ï 4,062¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 7¾ï 6,085¸¸ ´Þ·¯
CAGR(%) 32.24%

½ÃÀå ¿ªÇÐ : ½Å¼ÓÇÏ°Ô ÁøÈ­ÇÏ´Â ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÇÏ´Â ½ÃÀå ¿ªÇÐÀ» ÀÌÇØÇÏ¸é ºñÁî´Ï½º Á¶Á÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç °áÁ¤À» °³¼±Çϸç, »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ºñÁî´Ï½º Á¶Á÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÏ´Â µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å Æ®·»µå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½Å°æ°ú ¼ö¼ú¿ë AI ¼ö¿ä Áõ°¡
    • AI¸¦ Ȱ¿ëÇÑ ¼ö¼úÀÇ ÀÌÁ¡¿¡ °üÇÑ ÀÇ½Ä °íÁ¶
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·
  • ½ÃÀå ±âȸ
    • ³ú½Å°æ ¼ö¼ú½Ç¿ë AIÀÇ Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß Ȱµ¿
    • ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ ±âÈ£ÀÇ °íÁ¶
  • ½ÃÀå °úÁ¦
    • ¾ö°ÝÇÑ ±ÔÁ¦¿Í ±âÁØ¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷¿¡ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ¼³¸íÇÕ´Ï´Ù. ±â¾÷Àº PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ» ³»´Ùº» Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå¿¡¼­ °æÀï ±¸µµ¸¦ ÆÄ¾Ç

³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© ÀÚ»çÀÇ °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Á¦¾È : ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸®±â

³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀåÀÇ Àü·« ºÐ¼®Àº Àü ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ ÀÇ»ç°áÁ¤ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ³ú½Å°æ ¼ö¼ú¿ë AI ¼ö¿ä Áõ°¡
      • AI¸¦ Ȱ¿ëÇÑ ¼ö¼úÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎ½Ä È®´ë
    • ¾ïÁ¦¿äÀÎ
      • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·
    • ±âȸ
      • ³ú½Å°æ ¼ö¼ú½Ç¿ë AIÀÇ ¿¬±¸ °³¹ß Ȱµ¿ÀÇ °è¼Ó
      • ÃÖ¼Ò Ä§½À ¼ö¼ú¿¡ ´ëÇÑ °ü½É È®´ë
    • °úÁ¦
      • ¾ö°ÝÇÑ ±ÔÁ¦ ¹× ±âÁذú °ü·ÃµÈ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå : Á¦°ø Á¦Ç°º°

  • ¼Ò°³
  • ¼­ºñ½º
  • ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå : ¿ëµµº°

  • ¼Ò°³
  • ³ú ¸ÅÇÎ
  • °£Áú Áø´Ü
  • ÅëÇÕ°ú ¿¬°á
  • °á°ú ¹× À§Çè ºÐ¼®
  • ¼ö¼ú°èȹ

Á¦8Àå ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå : ÀûÀÀÁõº°

  • ¼Ò°³
  • ³ú½Å°æ ¿Ü°ú
  • ³ú½Å°æ ±â¼ú

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå

  • ¼Ò°³
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå

  • ¼Ò°³
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³ú½Å°æ ¼ö¼ú½Ç¿ë ÀΰøÁö´É ½ÃÀå

  • ¼Ò°³
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Activ Surgical Inc.
  • Brainomix Limited
  • Caresyntax Corporation
  • DeepOR SAS
  • ExplORer Surgical Corp.
  • GE HealthCare Technologies, Inc.
  • Getinge AB
  • Hill-Rom Holdings, Inc.
  • Holo Surgical Inc.
  • IMRIS inc.
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & CO. KG
  • Koninklijke Philips NV
  • LeanTaaS Inc.
  • Medtronic PLC
  • NeuroOne Medical Technologies Corporation
  • Proximie Limited
  • Scalpel Limited
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Surgalign Spine Technologies Inc.
  • Surgical Theater, Inc.
  • Theator Inc.
  • Toshiba Corporation
LYJ

The Artificial Intelligence in Neurology Operating Room Market was valued at USD 107.57 million in 2023, expected to reach USD 140.62 million in 2024, and is projected to grow at a CAGR of 32.24%, to USD 760.85 million by 2030.

The scope of Artificial Intelligence (AI) in the Neurology Operating Room encompasses a range of applications from pre-operative planning, intraoperative navigation, and post-operative analysis. AI technologies such as machine learning, computer vision, and robotic automation are necessary for enhancing precision, reducing human error, and improving surgical outcomes in neurology. Its applications span real-time data analysis, integration with imaging technologies, and aiding in minimally invasive procedures. The key end-users include neurosurgeons, hospitals, and specialized neurology clinics that benefit from AI-driven tools for improved patient care. Market growth is primarily influenced by advancements in AI technology, increasing cases of neurological disorders, and the demand for more efficient and effective surgical procedures. Emerging opportunities include the integration of AI with augmented reality for improved visualization, and predictive analytics for personalized patient care plans. However, challenges such as high initial costs, data privacy concerns, and the need for specialized training can hinder market growth. Additionally, regulatory hurdles and the slow adoption of AI technologies in healthcare settings pose significant limitations. The best areas for innovation and research include developing interoperable AI systems that can seamlessly integrate with existing hospital infrastructure and enhancing AI's ability to provide actionable insights from vast amounts of medical data. There is also potential in enhancing AI algorithms for greater accuracy in medical imaging and diagnostics. As the AI in the neurology operating room market matures, collaborations between tech companies and healthcare providers will be essential in driving innovation. Overall, the market is poised for significant growth, characterized by a dynamic landscape driven by technological innovation and an evolving regulatory framework. Businesses that invest in addressing existing challenges and focus on user-friendly, efficient AI solutions are likely to thrive in this burgeoning sector.

KEY MARKET STATISTICS
Base Year [2023] USD 107.57 million
Estimated Year [2024] USD 140.62 million
Forecast Year [2030] USD 760.85 million
CAGR (%) 32.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Neurology Operating Room Market

The Artificial Intelligence in Neurology Operating Room Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for AI in neurological operations
    • Growing awareness about the benefits of AI-powered surgeries
  • Market Restraints
    • Lack of skilled professionals
  • Market Opportunities
    • Ongoing research and development activities for AI in neurology operating room
    • Increasing preference for minimally invasive surgery
  • Market Challenges
    • Concerns associated with stringent regulations and standards

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Neurology Operating Room Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Neurology Operating Room Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Neurology Operating Room Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Neurology Operating Room Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Neurology Operating Room Market

A detailed market share analysis in the Artificial Intelligence in Neurology Operating Room Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Neurology Operating Room Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Neurology Operating Room Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Neurology Operating Room Market

A strategic analysis of the Artificial Intelligence in Neurology Operating Room Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Neurology Operating Room Market, highlighting leading vendors and their innovative profiles. These include Activ Surgical Inc., Brainomix Limited, Caresyntax Corporation, DeepOR S.A.S., ExplORer Surgical Corp., GE HealthCare Technologies, Inc., Getinge AB, Hill-Rom Holdings, Inc., Holo Surgical Inc., IMRIS inc., Johnson & Johnson Services, Inc., KARL STORZ SE & CO. KG, Koninklijke Philips N.V., LeanTaaS Inc., Medtronic PLC, NeuroOne Medical Technologies Corporation, Proximie Limited, Scalpel Limited, Siemens Healthcare GmbH, Stryker Corporation, Surgalign Spine Technologies Inc., Surgical Theater, Inc., Theator Inc., and Toshiba Corporation.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Neurology Operating Room Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Services and Software.
  • Based on Application, market is studied across Brain Mapping, Epilepsy Diagnosis, Integration & Connectivity, Outcomes & Risk Analysis, and Surgical Planning.
  • Based on Indication, market is studied across Neurosurgery and Neurotechnology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for AI in neurological operations
      • 5.1.1.2. Growing awareness about the benefits of AI-powered surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities for AI in neurology operating room
      • 5.1.3.2. Increasing preference for minimally invasive surgery
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with stringent regulations and standards
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Intelligence in Neurology Operating Room Market, by Offering

  • 6.1. Introduction
  • 6.2. Services
  • 6.3. Software

7. Artificial Intelligence in Neurology Operating Room Market, by Application

  • 7.1. Introduction
  • 7.2. Brain Mapping
  • 7.3. Epilepsy Diagnosis
  • 7.4. Integration & Connectivity
  • 7.5. Outcomes & Risk Analysis
  • 7.6. Surgical Planning

8. Artificial Intelligence in Neurology Operating Room Market, by Indication

  • 8.1. Introduction
  • 8.2. Neurosurgery
  • 8.3. Neurotechnology

9. Americas Artificial Intelligence in Neurology Operating Room Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Intelligence in Neurology Operating Room Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Intelligence in Neurology Operating Room Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Activ Surgical Inc.
  • 2. Brainomix Limited
  • 3. Caresyntax Corporation
  • 4. DeepOR S.A.S.
  • 5. ExplORer Surgical Corp.
  • 6. GE HealthCare Technologies, Inc.
  • 7. Getinge AB
  • 8. Hill-Rom Holdings, Inc.
  • 9. Holo Surgical Inc.
  • 10. IMRIS inc.
  • 11. Johnson & Johnson Services, Inc.
  • 12. KARL STORZ SE & CO. KG
  • 13. Koninklijke Philips N.V.
  • 14. LeanTaaS Inc.
  • 15. Medtronic PLC
  • 16. NeuroOne Medical Technologies Corporation
  • 17. Proximie Limited
  • 18. Scalpel Limited
  • 19. Siemens Healthcare GmbH
  • 20. Stryker Corporation
  • 21. Surgalign Spine Technologies Inc.
  • 22. Surgical Theater, Inc.
  • 23. Theator Inc.
  • 24. Toshiba Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦